Streetbeat News

Stock Prices

EBS

Emergent BioSolutions (NYSE:EBS) reported Q4 earnings with an EPS of $-0.77, missing estimates by -305.0% and a revenue decrease of $54.10 million from the previous year. This follows a pattern of missed EPS estimates in previous quarters, with a notable 3.0% share price drop after last quarter's earnings miss.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 9:50 pm

INO

Inovio Pharmaceuticals (NASDAQ:INO) reported Q4 earnings, beating estimated EPS by 13.0% with an EPS of $-1.1 versus an estimate of $-1.27. However, revenue was down $22 thousand from the same period last year. The company's past earnings performance shows a mixed trend with misses and beats in EPS over the last four quarters.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 9:50 pm

VSEC

VSE Corporation (NASDAQ:VSEC) reported Q4 earnings with an EPS of $0.85, beating estimates by 13.0% and showing a revenue increase of $1.00 million year-over-year. The company has a history of beating EPS estimates, which has previously led to a share price increase. VSE provided guidance for Q4 2023, expecting earnings between $0.85 and $0.85 per share.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 9:50 pm

PHVS

Pharvaris has filed for the resale of up to 5.55 million ordinary shares by a selling securityholder. This move could potentially impact the stock's liquidity and market perception.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 9:48 pm

ADT

ADT Inc (NYSE:ADT) shares fell after hours following the announcement of a secondary public offering of 55 million shares held by Apollo Global Management affiliates, with an option for underwriters to buy an additional 8.25 million shares. ADT will not sell any shares nor receive proceeds from the offering but will repurchase 15 million shares as part of its $350 million buyback program. Despite the drop, analysts, including George Tong from Goldman Sachs, view ADT as a Buy, expecting a 10.67% rise in the coming year.

Portfolio Pulse from Adam Eckert

March 06, 2024 | 9:48 pm

EXPR

Express, Inc. received a delisting notice from the NYSE, leading to the suspension of its common stock trading after market close on March 6, 2024. The stock will now trade on the OTC Pink Market under the symbol 'EXPR'.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 9:46 pm

MLR

Miller Industries reported a significant increase in its Q4 2023 earnings per share (EPS) to $1.45, up from $0.81 year-over-year (YoY). The company's revenue also saw a substantial rise, reaching $296.2 million, up from $225.9 million YoY.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 9:45 pm

AIRG

Airgain (NASDAQ:AIRG) reported Q4 earnings with an EPS of $-0.33, missing estimates by -65.0% and showing a revenue decrease of $9.82 million from the previous year. The company's past earnings performance shows a pattern of missed EPS estimates leading to significant share price drops.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 9:45 pm

ADT

ADT Inc. announced a secondary public offering of common stock along with a concurrent share repurchase, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 9:44 pm

CRGY

Crescent Energy Company (CRGY) announced a secondary public offering of 12M shares of Class A common stock by Independence Energy Aggregator L.P., with an option for underwriters to purchase an additional 1.8M shares. The company itself will not sell any shares or receive proceeds from this offering. Concurrently, Crescent plans to repurchase 2M OpCo Units from the Selling Stockholder, with the possibility of additional purchases if the underwriters exercise their option. Wells Fargo Securities, Evercore Group, and Raymond James are the joint book-running managers.

Portfolio Pulse from Happy Mohamed

March 06, 2024 | 9:43 pm